No black box warning on record for Terbinafine Hydrochloride

As of the latest FDA labeling reviewed, Terbinafine Hydrochloride (TERBINAFINE TABLETS 250 MG) does not carry a black box warning. Standard warnings and precautions still apply — see the full Terbinafine Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine. Obtain pretreatment serum transaminases. Prior to initiating treatment and periodically during therapy, assess liver function tests. Discontinue terbinafine tablets if liver injury develops. ( 5.1 ) Taste disturbance, including taste loss, has been reported with

No black box warning on record for Terbinafine Hydrochloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine. Obtain pretreatment serum transaminases. Prior to initiating treatment and periodically during therapy, assess liver function tests. Discontinue terbinafine tablets if liver injury develops. ( 5.1 ) Taste disturbance, including taste loss, has been reported with

Terbinafine Hydrochloride Black Box Warning

No black box warning on record for Terbinafine Hydrochloride

Other warnings & precautions

Terbinafine Hydrochloride Black Box Warning

No black box warning on record for Terbinafine Hydrochloride

Other warnings & precautions